Tci Wealth Advisors, Inc. Bristol Myers Squibb CO Transaction History
Tci Wealth Advisors, Inc.
- $1.52 Billion
- Q3 2025
A detailed history of Tci Wealth Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tci Wealth Advisors, Inc. holds 4,725 shares of BMY stock, worth $205,017. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,725
Previous 5,343
11.57%
Holding current value
$205,017
Previous $247,000
13.77%
% of portfolio
0.01%
Previous 0.02%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.63BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...